5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)picolinonitrile

ID: ALA4437080

Chembl Id: CHEMBL4437080

PubChem CID: 68204912

Max Phase: Preclinical

Molecular Formula: C26H18N6

Molecular Weight: 414.47

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(-c2nc(NCc3ccccn3)c3c(-c4ccccc4)cccc3n2)cn1

Standard InChI:  InChI=1S/C26H18N6/c27-15-20-13-12-19(16-29-20)25-31-23-11-6-10-22(18-7-2-1-3-8-18)24(23)26(32-25)30-17-21-9-4-5-14-28-21/h1-14,16H,17H2,(H,30,31,32)

Standard InChI Key:  GMCHQGJUBIJICJ-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNA5 Tclin Voltage-gated potassium channel subunit Kv1.5 (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.47Molecular Weight (Monoisotopic): 414.1593AlogP: 5.24#Rotatable Bonds: 5
Polar Surface Area: 87.38Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.53CX LogP: 5.28CX LogD: 5.28
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -1.47

References

1. Finlay HJ, Johnson JA, Lloyd JL, Jiang J, Neels J, Gunaga P, Banerjee A, Dhondi N, Chimalakonda A, Mandlekar S, Conder ML, Sale H, Xing D, Levesque P, Wexler RR..  (2016)  Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor.,  (9): [PMID:27660686] [10.1021/acsmedchemlett.6b00117]

Source